copyright (semaglutide) copyright, often called semaglutide, is often a prescription drug utilised to handle type 2 diabetes alongside diet plan and exercising. The drug, created by pharmaceutical corporation Novo Nordisk, can help strengthen blood sugar controls and lowers the potential risk of situations like heart assault or stroke. S.-only and